Engineers Gate Manager’s Enanta Pharmaceuticals ENTA Stock Holding History

Engineers Gate Manager’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$215K	Buy	+17,013	New	+$228K	﹤0.01%	1878
2025 Q1	–	Sell	-10,701	Closed	-$61.5K	–	2266
2024 Q4	$61.5K	Buy	+10,701	New	+$103K	﹤0.01%	2059
2024 Q1	–	Sell	-27,895	Closed	-$262K	–	2013
2023 Q4	$262K	Buy	+27,895	New	+$260K	0.01%	1525
2023 Q3	–	Sell	-10,178	Closed	-$218K	–	1873
2023 Q2	$218K	Buy	+10,178	New	+$300K	0.01%	1440
2020 Q3	–	Sell	-4,460	Closed	-$224K	–	1754
2020 Q2	$224K	Buy	+4,460	New	+$231K	0.01%	1386
2020 Q1	–	Sell	-7,520	Closed	-$465K	–	1665
2019 Q4	$465K	Buy	7,520 +1,263	+20%	+$78.3K	0.02%	1022
2019 Q3	$376K	Buy	6,257 +3,217	+106%	+$239K	0.02%	901
2019 Q2	$256K	Buy	+3,040	New	+$273K	0.01%	914
2015 Q3	–	Sell	-7,367	Closed	-$331K	–	733
2015 Q2	$331K	Buy	+7,367	New	+$287K	0.03%	771

Other funds holding ENTA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SSC

Spruce Street Capital New York $416M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Engineers Gate Manager's ENTA Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 17,013 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1878 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in ENTA as recently as Q4 2024.

Engineers Gate Manager first reported a position in ENTA in Q2 2015 and has held it in 9 quarters since. The position peaked at $465K in Q4 2019. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

Engineers Gate Manager held 17,013 shares of Enanta Pharmaceuticals worth $215K as of Q1 2026.
Enanta Pharmaceuticals was a new Engineers Gate Manager position in Q1 2026.
Enanta Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1878 holding.
Engineers Gate Manager first reported a position in Enanta Pharmaceuticals in Q2 2015 and has held it in 9 quarters since.
Engineers Gate Manager's Enanta Pharmaceuticals position peaked at $465K in Q4 2019.
132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.